Skip to content

Clinical trials

Phase 4 Psychotic Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 4 Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20031
20051
20061
20081
20111
20121
20131
20151
20161
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Central Institute of Mental Health, Mannheim3
Heinrich-Heine University, Duesseldorf3
Rene Kahn2
AstraZeneca1
Dr. Inge Winter1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Technical University of Munich1
University Hospital, Bonn1
University of Cologne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders14
Schizophrenia12
Prodromal Symptoms1
Schizophrenia Spectrum and Other Psychotic Disorders1
Schizophrenia, Paranoid1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.